CompletedNot Applicable

Prevalence and Risk Evaluation of Diabetic Complications of the Foot in A Large Canadian Population

Canada5,084 participantsStarted 2020-03-03

Plain-language summary

The study aims to assess foot complications among patients with diabetes in Canada, using patient data collected during diabetes foot assessments performed by the LMC Chiropody Team between February 27, 2018 and April 17, 2019.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years * Diagnosis of type 1 or type 2 diabetes * Under the care of an endocrinologist at LMC * Diabetes foot assessment was performed by the LMC Chiropody Team * Informed consent to use patient medical record data for research purposes was provided Exclusion Criteria: * Prior diabetes foot assessment by an LMC chiropodist

What they're measuring

Prevalence of diabetes foot complications: foot ulcer

Timeframe: 24-hours

Prevalence of diabetes foot complications: onychocryptosis

Timeframe: 24-hours

Prevalence of diabetes foot complications: onychomycosis

Timeframe: 24-hours

Prevalence of diabetes foot complications: onychauxis

Timeframe: 24-hours

Prevalence of diabetes foot complications: hyperkeratosis

Timeframe: 24-hours

Prevalence of diabetes foot complications: foot deformities

Timeframe: 24-hours

Prevalence of diabetes foot complications: neuropathy risk

Timeframe: 24-hours

Trial details

NCT IDNCT04327622

SponsorLMC Diabetes & Endocrinology Ltd.

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-06-30

View on ClinicalTrials.gov More Diabetes Mellitus, Type 2 trials